MedTrace Logo

The Mazira Project: An Evaluation of Eggs During Complementary Feeding in Rural Malawi

NCT03385252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 662

Last updated 2020-02-24

No results posted yet for this study

Summary

The Mazira Project is a study of the effect of egg consumption on growth, development and gut health of infants in Malawi. The study randomly assigns infants to receive one egg per day over six months or to receive an equivalent value of food at the end of six months. Growth, achievement of developmental milestones, gut microbiome composition and other measures of nutritional status are compared between the two groups to determine whether regular egg consumption benefits Malawian infants.

Conditions

  • Infant Malnutrition

Interventions

OTHER

Eggs

Eggs provided as complementary food for the infant

BEHAVIORAL

Visits

Twice weekly household visits by study staff

Sponsors & Collaborators

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Washington University School of Medicine

    collaborator OTHER

  • University of Maryland, College Park

    collaborator OTHER

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Christine P Stewart, PhD · University of California, Davis

  • Lora Iannotti, PhD · Washington University School of Medicine

  • Chessa Lutter, PhD · University of Maryland, College Park

  • Kenneth M Maleta, PhD · Kamuzu University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
9 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-22
Primary Completion
2019-01-22
Completion
2019-01-22

Countries

  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03385252 on ClinicalTrials.gov